Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Mabvax Therapeutics Holdings, Inc. (TELK) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Mabvax Therapeutics Holdings, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1109196.
Total stock buying since 2014: $86,487.
Total stock sales since 2014: $912,557.
Total stock option exercises since 2014: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2018 | 0 | $0 | 744,619 | $697,272 | 2,139,831 | $0 |
| 2017 | 24,341 | $21,298 | 31,431 | $65,033 | 84,511 | $0 |
| 2016 | 11,436 | $0 | 131,500 | $78,900 | 726,954 | $0 |
| 2015 | 8,500 | $19,549 | 0 | $0 | 0 | $0 |
| 2014 | 19,500 | $45,640 | 11,892 | $71,352 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2018-04 | 0 | $0 | 0 | $0 | 27,136 | $0 |
| 2018-01 | 0 | $0 | 744,619 | $697,272 | 2,112,695 | $0 |
| 2017-05 | 24,341 | $21,298 | 0 | $0 | 0 | $0 |
| 2017-04 | 0 | $0 | 31,431 | $65,033 | 84,511 | $0 |
| 2016-08 | 11,436 | $0 | 0 | $0 | 0 | $0 |
| 2016-04 | 0 | $0 | 0 | $0 | 726,954 | $0 |
| 2016-03 | 0 | $0 | 131,500 | $78,900 | 0 | $0 |
| 2015-05 | 8,500 | $19,549 | 0 | $0 | 0 | $0 |
| 2014-12 | 19,500 | $45,640 | 0 | $0 | 0 | $0 |
| 2014-09 | 0 | $0 | 11,892 | $71,352 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-04-03 | Varvaro Thomas C | Option Ex | 513 | .00 | 0 |
| 2018-04-02 | Cohen Kenneth M | Option Ex | 513 | .00 | 0 |
| 2018-04-02 | Hansen John David (PRESIDENT AND CEO) | Option Ex | 13,561 | .00 | 0 |
| 2018-04-02 | Hanson Gregory P (CHIEF FINANCIAL OFFICER, SECR) | Option Ex | 7,021 | .00 | 0 |
| 2018-04-02 | Maier Paul V | Option Ex | 513 | .00 | 0 |
| 2018-04-02 | Maffuid Paul W (EXEC. VP, R AND D) | Option Ex | 5,015 | .00 | 0 |
| 2018-01-24 | Varvaro Thomas C | Sale | 17,996 | .84 | 15,116 |
| 2018-01-24 | Cohen Kenneth M | Sale | 17,996 | .84 | 15,116 |
| 2018-01-24 | Eisenberg Jeffrey F | Sale | 17,998 | .84 | 15,118 |
| 2018-01-24 | Maier Paul V | Sale | 17,999 | .84 | 15,119 |
| 2018-01-23 | Varvaro Thomas C | Sale | 17,445 | .87 | 15,177 |
| 2018-01-23 | Cohen Kenneth M | Sale | 17,444 | .87 | 15,176 |
| 2018-01-23 | Eisenberg Jeffrey F | Sale | 17,444 | .87 | 15,176 |
| 2018-01-23 | Maier Paul V | Sale | 17,449 | .87 | 15,180 |
| 2018-01-16 | Resnick Paul F (VICE PRESIDENT, CBO) | Sale | 3,071 | .92 | 2,825 |
| 2018-01-16 | Hansen John David (PRESIDENT AND CEO) | Sale | 59,263 | .92 | 54,521 |
| 2018-01-16 | Hanson Gregory P (CHIEF FINANCIAL OFFICER, SECR) | Sale | 41,873 | .92 | 38,523 |
| 2018-01-16 | Maffuid Paul W (EXECUTIVE VICE PRESIDENT) | Sale | 38,054 | .92 | 35,009 |
| 2018-01-12 | Resnick Paul F (VICE PRESIDENT, CBO) | Sale | 824 | .96 | 791 |
| 2018-01-12 | Livingston Philip O. (CHIEF SCIENCE OFFICER) | Sale | 3,571 | .96 | 3,428 |
| 2018-01-12 | Hansen John David (PRESIDENT AND CEO) | Sale | 18,582 | .96 | 17,838 |
| 2018-01-12 | Hanson Gregory P (CHIEF FINANCIAL OFFICER, SECR) | Sale | 11,232 | .96 | 10,782 |
| 2018-01-12 | Maffuid Paul W (EXECUTIVE VICE PRESIDENT) | Sale | 10,207 | .96 | 9,798 |
| 2018-01-11 | Resnick Paul F (VICE PRESIDENT, CBO) | Sale | 2,837 | .98 | 2,780 |
| 2018-01-11 | Livingston Philip O. (CHIEF SCIENCE OFFICER) | Sale | 12,301 | .98 | 12,054 |
| 2018-01-11 | Hansen John David (PRESIDENT AND CEO) | Sale | 64,015 | .98 | 62,734 |
| 2018-01-11 | Hanson Gregory P (CHIEF FINANCIAL OFFICER, SECR) | Sale | 38,697 | .98 | 37,923 |
| 2018-01-11 | Maffuid Paul W (EXECUTIVE VICE PRESIDENT) | Sale | 35,166 | .98 | 34,462 |
| 2018-01-10 | Resnick Paul F (VICE PRESIDENT, CBO) | Sale | 4,879 | .96 | 4,683 |
| 2018-01-10 | Livingston Philip O. (CHIEF SCIENCE OFFICER) | Sale | 21,155 | .96 | 20,308 |
| 2018-01-10 | Hansen John David (PRESIDENT AND CEO) | Sale | 110,093 | .96 | 105,689 |
| 2018-01-10 | Hanson Gregory P (CHIEF FINANCIAL OFFICER, SECR) | Sale | 66,550 | .96 | 63,888 |
| 2018-01-10 | Maffuid Paul W (EXECUTIVE VICE PRESIDENT) | Sale | 60,478 | .96 | 58,058 |
| 2018-01-08 | Resnick Paul F (VICE PRESIDENT, CBO) | Option Ex | 29,944 | .00 | 0 |
| 2018-01-08 | Livingston Philip O. (CHIEF SCIENCE OFFICER) | Option Ex | 100,000 | .00 | 0 |
| 2018-01-08 | Varvaro Thomas C | Option Ex | 100,000 | .00 | 0 |
| 2018-01-08 | Cohen Kenneth M | Option Ex | 100,000 | .00 | 0 |
| 2018-01-08 | Eisenberg Jeffrey F | Option Ex | 100,000 | .00 | 0 |
| 2018-01-08 | Hansen John David (PRESIDENT AND CEO) | Option Ex | 727,210 | .00 | 0 |
| 2018-01-08 | Hanson Gregory P (CHIEF FINANCIAL OFFICER, SECR) | Option Ex | 449,159 | .00 | 0 |
| 2018-01-08 | Maier Paul V | Option Ex | 100,000 | .00 | 0 |
| 2018-01-08 | Maffuid Paul W (EXECUTIVE VICE PRESIDENT) | Option Ex | 406,382 | .00 | 0 |
| 2017-05-19 | Hansen John David (PRESIDENT AND CEO) | Buy | 9,128 | .88 | 7,987 |
| 2017-05-19 | Hanson Gregory P (CHIEF FINANCIAL OFFICER, SECR) | Buy | 9,128 | .88 | 7,987 |
| 2017-05-19 | Maffuid Paul W (EXECUTIVE VICE PRESIDENT) | Buy | 6,085 | .88 | 5,324 |
| 2017-04-12 | Hansen John David (PRESIDENT AND CEO) | Sale | 10,216 | 2.00 | 20,432 |
| 2017-04-12 | Hanson Gregory P (CHIEF FINANCIAL OFFICER, SECR) | Sale | 3,885 | 2.00 | 7,770 |
| 2017-04-12 | Maffuid Paul W (EXECUTIVE VICE PRESIDENT) | Sale | 1,369 | 2.00 | 2,738 |
| 2017-04-11 | Hansen John David (PRESIDENT AND CEO) | Sale | 250 | 2.00 | 500 |
| 2017-04-11 | Hanson Gregory P (CHIEF FINANCIAL OFFICER, SECR) | Sale | 200 | 2.00 | 400 |
| 2017-04-11 | Maffuid Paul W (EXECUTIVE VICE PRESIDENT) | Sale | 200 | 2.00 | 400 |
| 2017-04-10 | Hansen John David (PRESIDENT AND CEO) | Sale | 560 | 2.00 | 1,120 |
| 2017-04-10 | Hanson Gregory P (CHIEF FINANCIAL OFFICER, SECR) | Sale | 400 | 2.00 | 800 |
| 2017-04-10 | Maffuid Paul W (EXECUTIVE VICE PRESIDENT) | Sale | 400 | 2.00 | 800 |
| 2017-04-07 | Hansen John David (PRESIDENT AND CEO) | Sale | 666 | 2.00 | 1,335 |
| 2017-04-07 | Hanson Gregory P (CHIEF FINANCIAL OFFICER, SECR) | Sale | 450 | 2.00 | 902 |
| 2017-04-07 | Maffuid Paul W (EXECUTIVE VICE PRESIDENT) | Sale | 450 | 2.00 | 902 |
| 2017-04-06 | Hansen John David (PRESIDENT AND CEO) | Sale | 1,501 | 2.15 | 3,224 |
| 2017-04-06 | Hanson Gregory P (CHIEF FINANCIAL OFFICER, SECR) | Sale | 867 | 2.15 | 1,862 |
| 2017-04-06 | Maffuid Paul W (EXECUTIVE VICE PRESIDENT) | Sale | 867 | 2.15 | 1,862 |
| 2017-04-05 | Hansen John David (PRESIDENT AND CEO) | Sale | 2,450 | 2.15 | 5,269 |
| 2017-04-05 | Hanson Gregory P (CHIEF FINANCIAL OFFICER, SECR) | Sale | 1,800 | 2.15 | 3,871 |
| 2017-04-05 | Maffuid Paul W (EXECUTIVE VICE PRESIDENT) | Sale | 1,800 | 2.15 | 3,871 |
| 2017-04-04 | Hansen John David (PRESIDENT AND CEO) | Sale | 1,100 | 2.25 | 2,475 |
| 2017-04-04 | Hanson Gregory P (CHIEF FINANCIAL OFFICER, SECR) | Sale | 1,000 | 2.25 | 2,250 |
| 2017-04-04 | Maffuid Paul W (EXECUTIVE VICE PRESIDENT) | Sale | 1,000 | 2.25 | 2,250 |
| 2017-04-02 | Ravetch Jeffrey V. | Option Ex | 1,543 | .00 | 0 |
| 2017-04-02 | Varvaro Thomas C | Option Ex | 1,543 | .00 | 0 |
| 2017-04-02 | Cohen Kenneth M | Option Ex | 1,543 | .00 | 0 |
| 2017-04-02 | Hansen John David (PRESIDENT AND CEO) | Option Ex | 40,687 | .00 | 0 |
| 2017-04-02 | Hanson Gregory P (CHIEF FINANCIAL OFFICER, SECR) | Option Ex | 21,064 | .00 | 0 |
| 2017-04-02 | Maier Paul V | Option Ex | 1,543 | .00 | 0 |
| 2017-04-02 | Maffuid Paul W (EXECUTIVE VICE PRESIDENT) | Option Ex | 15,045 | .00 | 0 |
| 2017-04-02 | Hoffman Robert | Option Ex | 1,543 | .00 | 0 |
| 2016-08-17 | Cohen Kenneth M | Buy | 3,119 | .00 | 0 |
| 2016-08-17 | Hansen John David (PRESIDENT AND CEO) | Buy | 3,119 | .00 | 0 |
| 2016-08-17 | Hanson Gregory P (CHIEF FINANCIAL OFFICER, SECR) | Buy | 3,119 | .00 | 0 |
| 2016-08-17 | Maffuid Paul W (EXECUTIVE VICE PRESIDENT) | Buy | 2,079 | .00 | 0 |
| 2016-04-04 | Scholz Wolfgang W. (VP OF ANTIBODY DISCOVERY) | Option Ex | 101,584 | .00 | 0 |
| 2016-04-04 | Ravetch Jeffrey V. | Option Ex | 11,417 | .00 | 0 |
| 2016-04-04 | Varvaro Thomas C | Option Ex | 11,417 | .00 | 0 |
| 2016-04-04 | Cohen Kenneth M | Option Ex | 11,417 | .00 | 0 |
| 2016-04-04 | Hansen John David (PRESIDENT AND CEO) | Option Ex | 301,084 | .00 | 0 |
| 2016-04-04 | Hanson Gregory P (CHIEF FINANCIAL OFFICER, SECR) | Option Ex | 155,867 | .00 | 0 |
| 2016-04-04 | Maier Paul V | Option Ex | 11,417 | .00 | 0 |
| 2016-04-04 | Maffuid Paul W (EXECUTIVE VICE PRESIDENT) | Option Ex | 111,334 | .00 | 0 |
| 2016-04-04 | Hoffman Robert | Option Ex | 11,417 | .00 | 0 |
| 2016-03-24 | Ravetch Jeffrey V. | Sale | 131,500 | .60 | 78,900 |
| 2015-05-29 | Maier Paul V | Buy | 5,000 | 2.30 | 11,500 |
| 2015-05-22 | Cohen Kenneth M | Buy | 3,500 | 2.30 | 8,049 |
| 2014-12-17 | Cohen Kenneth M (Director) | Buy | 2,500 | 1.80 | 4,500 |
| 2014-12-16 | Cohen Kenneth M (Director) | Buy | 4,000 | 2.41 | 9,640 |
| 2014-12-16 | Hanson Gregory P (Chief Financial Officer) | Buy | 3,000 | 2.50 | 7,500 |
| 2014-12-16 | Hoffman Robert (Director) | Buy | 10,000 | 2.40 | 24,000 |
| 2014-09-12 | Antonopoulos Jim J. (Other) | Sale | 11,892 | 6.00 | 71,352 |
Insider trading activities including stock purchases, stock sales, and option exercises of TELK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Mabvax Therapeutics Holdings, Inc. (symbol TELK, CIK number 1109196) see the Securities and Exchange Commission (SEC) website.